Merck Drops ITC Probe Into Patented Folate Supplements

By Bill Donahue (June 11, 2013, 7:25 PM EDT) -- A subsidiary of Swiss Merck KgaA and others have asked the U.S. International Trade Commission to drop its probe into allegations that smaller rivals were importing generic folate supplements that contained patent-protected ingredients, according to papers filed Monday.

Merck & Cie, Pamlab LLC — now a Nestle S.A. subsidiary — and South Alabama Medical Science Foundation asked the trade body to halt its investigation into Gnosis SpA, Macoven Pharmaceuticals Inc. and Viva Pharmaceutical Inc. while the agency considers joint motions to terminate the probe.

Merck and the others had accused the respondents of violating Section 337 of the Tariff Act of...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!